Reaching new heights in biomarker solutions Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
In Safe Hands Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Setting New Standards Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Ahead of the Pack Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Leading from the Front Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications

Biomarker Assays

Biomarker Assays
Rapid development of TMT-SRM mass spectrometry assays for biomarker validation and routine measurement Learn More

Biomarker Services

Biomarker Services
Unique peptidomic and proteomic workflows using TMT with LTQ Orbitrap for maximum coverage in discovery and validation Learn More

Proprietary Biomarkers

Proprietary Biomarkers
Biomarkers for Alzheimer's disease, stroke, cancer and other indications Learn More

What's new

Proteome Sciences to receive the Science & Technology Award for TMT at the upcoming HUPO World Congress

Learn More

News

1 of 3
28 Nov, 2014 / SysQuant® – Update/Contract Awards The board is pleased to announce that the further assessment of an additional 20 cases of pancreatic cancer using SysQuant® has recently been completed. The results validate the findings from the first 12 cases that were published earlier this year in PLOS ONE.
Read More
02 Oct, 2014 / Director Dealing The Board of Proteome announces that Geoff Ellis, Finance Director, has today been granted options over 300,000 ordinary shares of 1p each under the Company’s 2011 Long Term Incentive Plan (“LTIP”).
Read More

Events

18 Mar, 2015 / AD/PD International Conference The 12th International Conference on Alzheimer's and Parkinson's Diseases and related neurological…

Read More